APGE
NASDAQ · Biotechnology
Apogee Therapeutics Inc
$135.07
-0.01 (-0.01%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+251.56%
YTD
+78.24%
Open$135.08
Previous Close$135.08
Day High$135.09
Day Low$135.06
52W High$135.09
52W Low$35.39
Volume—
Avg Volume1.54M
Market Cap10.22B
P/E Ratio—
EPS$-4.34
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$73.88
Above
SMA 200
$52.13
Above
RSI (14)
48.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
21 analysts
Price Target
-24.8% upside
Current
$135.07
$135.07
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 911.35M | 871.62M | 948.06M |
| Net Income | -243,438,723 | -174,175,180 | -203,637,440 |
| Profit Margin | -26.7% | -20.0% | -21.5% |
| EBITDA | -267,934,128 | -228,786,100 | -261,593,713 |
| Free Cash Flow | -101,879,133 | -97,401,406 | -128,866,616 |
| Rev Growth | +22.2% | +5.3% | +12.3% |
| Debt/Equity | 0.88 | 0.85 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.08 | -0.05% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.09 | -1.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.37 | -0.85% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $516.34 | +0.26% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $801.82 | -0.26% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.51 | -2.04% | 40.0 | 32.33B |